semaglutide and marijuana GLP-1 boom nudges cannabis dispensaries to rethink offerings | The Mighty 790 KFGO Optimal Cannabis Dosing - MMTC

Key takeaways from strategies to succeed in the obesity market: Monitor the evolving access landscape Identify high-value partnerships Develop novel HCP strategies Secure clinical and market access strategy differentiation As the healthcare landscape evolves, successful strategies will depend on a data-driven understanding of key adoption trends, access stakeholder priorities (e.g., payer, employer, PBMs), and high-impact technological areas

You'll get fast, discreet home delivery and real support from start to finish

Combining incretin-based medicines could compound gastrointestinal effects, dehydration risk, and hypoglycemia risk when other glucose-lowering drugs are involved

One real-world evidence study found that patients receiving GLP-1 receptor agonists had a higher risk of ulcerative colitis compared to those on DPP-4 inhibitors (a different diabetes drug class)

But with these new guidelines, the conversation is shifting toward how they can be used safely and effectively